查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1765127

全球非血管支架市場

Non-Vascular Stents
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球非血管支架市場規模將達到 22 億美元

全球非血管支架市場規模預計在2024年為16億美元，預計到2030年將達到22億美元，2024年至2030年的複合年成長率為5.1%。泌尿系統支架是本報告分析的細分市場之一，預計其複合年成長率為5.1%，到分析期結束時將達到11億美元。胃腸道支架市場在分析期間內的複合年成長率預計為5.3%。

美國市場規模估計為 4.459 億美元，中國市場預期複合年成長率為 4.9%

美國非血管支架市場規模預計2024年達到4.459億美元。作為世界第二大經濟體，中國市場規模預計到2030年將達到3.473億美元，在2024-2030年的分析期間內，複合年成長率為4.9%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為4.8%和4.4%。在歐洲，預計德國市場的複合年成長率為4.8%。

全球非血管支架市場－主要趨勢與促進因素摘要

什麼是非血管支架？為什麼它們對患者照護至關重要？

非血管支架是用來支撐和維持消化器官系統、泌尿器官系統和呼吸系統等非血管通道暢通的醫療設備。這些支架主要用於治療因腫瘤、狹窄以及食道、膽管、輸尿管和氣道等器官的其他阻塞所引起的阻塞。與動脈和靜脈中使用的血管支架不同，非血管支架專注於緩解軟組織器官的阻塞並維持正常的身體功能，例如呼吸、排尿和消化。非血管支架所使用的材料範圍從金屬合金到生物分解性的聚合物，可根據患者的具體情況量身定做解決方案。在因癌症導致這些系統阻塞的患者的安寧療護中，非血管支架的使用正變得越來越重要。

科技進步如何徹底改變非血管支架市場？

非血管支架市場近年來經歷了重大創新，尤其是在先進材料和支架設計的發展方面。生物分解性支架（一段時間後可溶解）因其可減少再次手術移除支架的需求而日益普及。此外，藥物釋放型（緩慢釋放藥物以防止支架周圍組織發炎和增生）也正廣泛應用。支架靈活性的提高以及自動擴張型支架的開發使其更易於植入，並降低了手術風險。這些技術進步使阻塞治療更加精準、創傷更小，從而改善了患者的治療效果並縮短了康復時間。隨著微創手術的日益普及，非血管支架擴大被用作各種疾病的解決方案，尤其適用於那些不適合接受創傷性手術的患者。

人口和醫療保健趨勢如何影響非血管支架市場？

癌症、胃腸道疾病和慢性阻塞性肺病(COPD) 等疾病的盛行率上升是推動非血管支架需求的主要因素。全球人口老化導致膽道、泌尿系統和呼吸道阻塞疾病的盛行率上升。這些人口變化持續推動著安寧療護和治療中對支架置入術手術的需求。此外，醫療保健基礎設施的進步，特別是新興市場的進步，正在擴大非血管支架等醫療設備的可近性，增加先前服務不足地區對醫療技術的採用。此外，對患者舒適度和生活品質的日益重視，特別是在腫瘤學領域，正在推動人們越來越依賴非血管支架作為緩解阻塞症狀的解決方案。

哪些因素推動了非血管支架市場的成長？

非血管支架市場的成長受到多種因素的推動。自動擴張型支架和藥物釋放型支架的開發等技術進步改善了治療效果並減少了併發症，從而導致這些設備的廣泛採用。此外，癌症和慢性病的盛行率不斷上升，特別是人口老化，也推動了對非血管支架的需求，而非血管支架對於安寧療護至關重要。此外，微創手術的轉變推動了支架取代更具侵入性的手術方法的應用，特別是對於老年和嚴重患者。新興市場醫療保健管道的擴大和醫療基礎設施投資的增加，為非血管支架市場創造了新的機會。最後，個人化醫療的趨勢（客製化支架設計以滿足特定患者的需求）進一步推動了市場的成長。

部分

產品類型（泌尿系統支架、胃腸道支架、肺動脈支架、其他產品類型）

受訪公司範例

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, sro
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 其他地區

第4章 競賽

簡介目錄
Product Code: MCP13622

Global Non-Vascular Stents Market to Reach US$2.2 Billion by 2030

The global market for Non-Vascular Stents estimated at US$1.6 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Urology Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Gastrointestinal Stents segment is estimated at 5.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.9 Million While China is Forecast to Grow at 4.9% CAGR

The Non-Vascular Stents market in the U.S. is estimated at US$445.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$347.3 Million by the year 2030 trailing a CAGR of 4.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.8% and 4.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Global Non-Vascular Stents Market - Key Trends & Drivers Summarized

What Are Non-Vascular Stents and Why Are They Crucial for Patient Care?

Non-vascular stents are medical devices used to support and keep open passageways in non-vascular systems, such as the digestive, urinary, and respiratory tracts. These stents are primarily used to treat obstructions caused by tumors, strictures, or other blockages in organs such as the esophagus, bile ducts, ureters, and airways. Unlike vascular stents, which are used in arteries and veins, non-vascular stents focus on relieving obstructions in soft tissue organs, ensuring normal bodily functions like breathing, urination, or digestion are maintained. Materials used for non-vascular stents range from metal alloys to biodegradable polymers, allowing for tailored solutions based on the patient’s specific condition. The use of non-vascular stents has become increasingly important in palliative care for patients with cancers that lead to blockages in these systems.

How Are Technological Advancements Revolutionizing the Non-Vascular Stents Market?

The non-vascular stents market has seen significant innovation in recent years, particularly with the development of advanced materials and stent designs. Biodegradable stents, which dissolve after a certain period, are gaining traction as they reduce the need for repeat procedures to remove the stent. Additionally, drug-eluting stents, which slowly release medication to prevent tissue inflammation or growth around the stent, are becoming more widely adopted. Improvements in stent flexibility and the development of self-expanding stents have enhanced the ease of implantation and reduced procedural risks. These technological advancements allow for more precise and less invasive treatment of blockages, improving patient outcomes and recovery times. As minimally invasive procedures gain popularity, non-vascular stents are increasingly being deployed as a solution for a range of conditions, particularly in patients who are not ideal candidates for more invasive surgeries.

How Are Demographic and Healthcare Trends Impacting the Non-Vascular Stents Market?

The rising incidence of diseases such as cancer, gastrointestinal disorders, and chronic obstructive pulmonary disease (COPD) is one of the primary drivers of demand for non-vascular stents. With aging populations across the globe, there is an increasing prevalence of conditions that lead to obstructions in the biliary, urinary, and respiratory tracts. This demographic shift is creating sustained demand for stenting procedures as part of both palliative and curative care. Moreover, advancements in healthcare infrastructure, particularly in emerging markets, have expanded access to medical devices such as non-vascular stents, increasing their adoption in regions previously underserved by medical technology. Additionally, the growing emphasis on patient comfort and quality of life, particularly in oncology, has led to a greater reliance on non-vascular stents as a solution to alleviate symptoms caused by obstructions.

What Factors Are Driving Growth in the Non-Vascular Stents Market?

The growth in the non-vascular stents market is driven by several factors. Technological advancements, such as the development of self-expanding and drug-eluting stents, are enhancing treatment outcomes and reducing complications, which in turn is driving wider adoption of these devices. The increasing prevalence of cancer and chronic diseases, particularly in aging populations, is also fueling demand for non-vascular stents as an essential part of palliative care. Furthermore, the shift toward minimally invasive procedures is driving the adoption of stents over more invasive surgical options, particularly for elderly patients or those with severe conditions. Expanding healthcare access in emerging markets, combined with growing investments in medical infrastructure, is opening up new opportunities for the non-vascular stents market. Finally, the trend toward personalized medicine, with customized stent designs for specific patient needs, is further bolstering market growth.

SCOPE OF STUDY:

The report analyzes the Non-Vascular Stents market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Urology Stents, Gastrointestinal Stents, Pulmonary Stents, Other Product Types)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

  • BARD, A Becton, Dickinson Company
  • Boston Scientific Corporation
  • ConMed Corporation
  • Cook Medical, Inc.
  • ELLA-CS, s.r.o.
  • Glaukos Corporation
  • Hobbs Medical, Inc.
  • Medtronic PLC
  • Synchron, Inc.
  • Taewoong Medical

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Non-Vascular Stents - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Gastrointestinal Disorders Drives Demand for Non-Vascular Stents in Endoscopic Procedures
    • Increasing Adoption of Urological Stents Expands Market for Non-Vascular Solutions in Kidney and Urinary Tract Treatments
    • Growing Use of Biliary Stents Fuels Market Growth in the Treatment of Bile Duct Obstructions and Gallstones
    • Technological Advancements in Self-Expanding Stents Propel Growth in Non-Vascular Applications for Digestive Health
    • Rising Demand for Non-Vascular Stents in Colorectal Cancer Treatment Expands Market for Minimally Invasive Oncology Solutions
    • Increasing Use of Pancreatic Stents Strengthens Market for Non-Vascular Stents in Gastrointestinal Surgeries
    • Emerging Focus on Non-Vascular Stents for Airway Management Fuels Growth in Respiratory and Pulmonary Applications
    • Rising Adoption of Non-Vascular Stents in Palliative Care Expands Opportunities for End-of-Life Interventions
    • Growing Demand for Non-Vascular Stents in Pediatric Patients Expands Market for Specialized Stenting Solutions
    • Technological Innovations in Biodegradable and Drug-Eluting Non-Vascular Stents Propel Growth in Long-Term Treatment Solutions
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Non-Vascular Stents Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Non-Vascular Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Urology Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Urology Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Gastrointestinal Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Gastrointestinal Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pulmonary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Pulmonary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 20: Canada Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Canada Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Canada 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 23: Japan Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Japan Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: Japan 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • CHINA
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 26: China Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: China Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: China 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Non-Vascular Stents by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Non-Vascular Stents by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 32: Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Europe 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 35: France Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: France Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: France 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 38: Germany Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Germany Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Germany 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 41: Italy Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Italy Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Italy 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 44: UK Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: UK Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: UK 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 47: Rest of Europe Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Rest of Europe Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Rest of Europe 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Non-Vascular Stents Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 50: Asia-Pacific Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Asia-Pacific Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Asia-Pacific 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 53: Rest of World Recent Past, Current & Future Analysis for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Rest of World Historic Review for Non-Vascular Stents by Product Type - Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Rest of World 15-Year Perspective for Non-Vascular Stents by Product Type - Percentage Breakdown of Value Sales for Urology Stents, Gastrointestinal Stents, Pulmonary Stents and Other Product Types for the Years 2015, 2025 & 2030

IV. COMPETITION